Skip to content
Disclosery

ORBIMED ADVISORS LLC: CRVS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on CRVS, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 7,165,006 CRVS shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 7,165,006 shares
    Change vs previous 13F 0 shares

    2.03% of the 13F portfolio, value $107,045,190.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 7,165,006 shares
    Change vs previous 13F 0 shares

    2.29% of the 13F portfolio, value $104,824,038.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 7,165,006 shares
    Change vs previous 13F 0 shares

    1.13% of the 13F portfolio, value $55,170,546.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 7,165,006 shares
    Change vs previous 13F 0 shares

    1.27% of the 13F portfolio, value $52,806,094.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 7,165,006 shares
    Change vs previous 13F +221,352 shares

    0.72% of the 13F portfolio, value $28,660,024.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 6,943,654 shares
    Change vs previous 13F 0 shares

    0.53% of the 13F portfolio, value $22,080,820.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 6,943,654 shares
    Change vs previous 13F 0 shares

    0.77% of the 13F portfolio, value $37,148,549.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 6,943,654 shares
    Change vs previous 13F not available

    0.67% of the 13F portfolio, value $36,662,493.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).